☕ DECAF Trial insight!
A new JAMA study shows that daily caffeinated coffee may lower recurrence of atrial fibrillation compared with abstinence.
Patients drinking ~1 cup/day had 47% recurrence vs 64% with abstinence (HR 0.61, p=0.01) 📉💓
No major safety concerns—challenging long-held beliefs that coffee is proarrhythmic.
💡Takeaway: For many patients with AF, enjoying their morning brew may be both safe and possibly beneficial.
#AtrialFibrillation #Cardiology #JAMA #ClinicalTrials #HeartHealth ☕💓📊
